FALCO HOLDINGS Co., Ltd. (TYO:4671)

Market Cap	26.62B +6.5%
Revenue (ttm)	43.65B +0.3%
Net Income	2.08B +5.1%
EPS	207.20 +9.8%
Shares Out	9.97M
PE Ratio	12.79
Forward PE	n/a
Dividend	128.00 (4.79%)
Ex-Dividend Date	Sep 29, 2026

Volume	16,900
Open	2,641.00
Previous Close	2,650.00
Day's Range	2,641.00 - 2,693.00
52-Week Range	2,463.00 - 2,964.00
Beta	0.32
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 6, 2026

About FALCO HOLDINGS

FALCO HOLDINGS Co., Ltd., a medical service company, provides clinical testing and dispensing pharmacy services to medical institutions and companies in Japan. The company offers clinical testing services in the fields of genetic tests, biochemistry, hematology, pathology, immunology, and microbiology; and genetic testing services for diagnosis of hereditary cancer, reproductive health and companion diagnostics. It also provides medical information technology services; and develops in vitro diagnostics for unmet medical needs. In addition, the ...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 1962
• Employees: 1,037
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4671

Financial Performance

In fiscal year 2026, FALCO HOLDINGS's revenue was 43.58 billion, an increase of 0.61% compared to the previous year's 43.31 billion. Earnings were 2.02 billion, an increase of 5.00%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 9, 2026

Data Sources Report a data error